FDA warns about limits of SARS-CoV-2 antibody tests | The Daily Star
12:00 AM, April 26, 2020 / LAST MODIFIED: 12:00 AM, April 26, 2020

FDA warns about limits of SARS-CoV-2 antibody tests

The U.S. Food and Drug Administration (FDA) recently issued a letter warning healthcare providers about the limits of serological tests to detect SARS-CoV-2 antibodies. The agency is urging clinicians to "not use serological (antibody) tests as the sole basis to diagnose COVID-19 but instead as information about whether a person may have been exposed."

In mid-March, the FDA "provided regulatory flexibility" for test developers, the agency noted, which has resulted in scores of antibody tests quickly hitting the market without the agency's usual review. As of April 18, just four antibody assays had received emergency use authorisation from the FDA.

The agency said it "is not aware of an antibody test that has been validated for diagnosis of SARS-CoV-2 infection." The tests measure IgM or IgG antibodies, but IgM antibodies may not develop at all, and IgG antibodies usually do not develop until later in the disease process. Therefore, using such tests to diagnose COVID-19 will miss infections.

 

Stay updated on the go with The Daily Star Android & iOS News App. Click here to download it for your device.

Grameenphone:
Type START <space> BR and send SMS it to 22222

Robi:
Type START <space> BR and send SMS it to 2222


Banglalink:
Type START <space> BR and send SMS it to 2225

Leave your comments

Top News

Top News

Top